1 / 7

Hepatitis E Diagnostic Tests Market is anticipated to rise at a CAGR of 3.80% from 2016 to 2024

The global hepatitis E diagnostic tests market stood at US$43.7 mn in 2015. Expanding at a CAGR of 3.80% during the period from 2016 to 2024, the opportunity in hepatitis E diagnostic tests market is likely to increase to US$60.4 mn by the end of the forecast period.

Download Presentation

Hepatitis E Diagnostic Tests Market is anticipated to rise at a CAGR of 3.80% from 2016 to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ©2019 Transparency Market Research, All Rights Reserved Hepatitis E Diagnostic Tests Market Test Type - ELISA HEV IgM Test kits, ELISA HEV IgG Test Kits, and RT-PCR Test Kits; End User - Hospitals, Diagnostic Laboratories, Research Centers, and Point of Care Forecast From - 2016 - 2024 ©2019 Transparency Market Research, All Rights Reserved

  2. ©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary: Global Hepatitis E Diagnostic Tests Market Chapter 4 Market Overview Chapter 5 Global Hepatitis E Diagnostic Tests Market Analysis and Forecasts, By Test Type Chapter 6 Global Hepatitis E Diagnostic Tests Market Analysis and Forecasts, By End User Chapter 7 Global Hepatitis E Diagnostic Tests Market Analysis and Forecasts, By Region Chapter 8 North America Hepatitis E Diagnostic Tests Market Analysis and Forecast Chapter 9 Latin America Hepatitis E Diagnostic Tests Market Analysis and Forecast Chapter 10 Europe Hepatitis E Diagnostic Tests Market Analysis and Forecast Chapter 11 Asia Pacific Hepatitis E Diagnostic Tests Market Analysis and Forecast Chapter 12 Middle East & Africa Hepatitis E Diagnostic Tests Market Analysis and Forecast Chapter 13 Competition Landscape

  3. ©2019 Transparency Market Research, All Rights Reserved Competition Landscape: Snapshot • Hepatitis E is a liver disease that is enterically transmitted and is caused by hepatitis E virus (HEV). Among the different types of diagnostic tests for hepatitis E, the primary tests are ELISA HEV IgM test kits, ELISA HEV IgG test kits, and RT-PCR test kits. The market has witnessed an extensive demand for ELISA HEV IgM test kits. • Global Hepatitis E Diagnostic Tests Market is segmented into Europe, Asia Pacific, Latin America, North America, and the Middle East and Africa. Of these, Asia Pacific is the leading regional market. • ©2019 Transparency Market Research, All Rights Reserved

  4. ©2019 Transparency Market Research, All Rights Reserved ©2019 Transparency Market Research, All Rights Reserved

  5. ©2019 Transparency Market Research, All Rights Reserved Reports Highlights • Global hepatitis E diagnostic tests market is anticipated to rise at a CAGR of 3.80% from 2016 to 2024. The market was valued at US$43.7 mn in 2015 and expected to reach US$60.4 mn by the end of the forecast period. • Key Player - Pharmacy, Primerdesign Ltd., Mikrogen GmBH, MP Biomedicals LLC, Fast- track diagnostics Ltd., Fortress Diagnostics Ltd., F. Hoffmann-La Roche Ltd., Biokit S.A., and Altana Diagnostics GmbH. ©2019 Transparency Market Research, All Rights Reserved Request Sample

  6. ©2019 Transparency Market Research, All Rights Reserved Continue.. • In September, 2017, Amgen Inc. And ALLERGAN Collectively Obtained FDA Approval For The Use Of MVASI To Treat Five Types Of Cancer. • Continuous Launch Of New Products And Increase In The Number Of Patients In DevelopedAnd Developing Countries. • Expansion Of Drugs Delivery System Portfolio: By Improving Existing Drug Delivery Devices And Developing And Launching Of New Drug Delivery System Through Collaboration. ©2019 Transparency Market Research, All Rights Reserved Request Brochure

  7. ©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U

More Related